KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iQIYI (IQ) Common Equity (2021 - 2025)

iQIYI has reported Common Equity over the past 5 years, most recently at $1.9 billion for Q4 2025.

  • Quarterly results put Common Equity at $1.9 billion for Q4 2025, up 0.79% from a year ago — trailing twelve months through Dec 2025 was $1.9 billion (up 0.79% YoY), and the annual figure for FY2025 was $1.9 billion, up 3.87%.
  • Common Equity for Q4 2025 was $1.9 billion at iQIYI, up from $1.9 billion in the prior quarter.
  • Over the last five years, Common Equity for IQ hit a ceiling of $1.9 billion in Q4 2025 and a floor of $825.2 million in Q4 2021.
  • Median Common Equity over the past 5 years was $1.7 billion (2023), compared with a mean of $1.4 billion.
  • Biggest five-year swings in Common Equity: skyrocketed 89.74% in 2023 and later increased 0.79% in 2025.
  • iQIYI's Common Equity stood at $825.2 million in 2021, then rose by 8.09% to $891.9 million in 2022, then skyrocketed by 89.74% to $1.7 billion in 2023, then rose by 10.02% to $1.9 billion in 2024, then grew by 0.79% to $1.9 billion in 2025.
  • The last three reported values for Common Equity were $1.9 billion (Q4 2025), $1.9 billion (Q4 2024), and $1.7 billion (Q4 2023) per Business Quant data.